Newsletter / Q2 2026Contact us at info@reflowmedical.com. Developing easy-to-use products designed by and for physicians On June 1, we celebrated milestones made possible by our employees, physician partners, distribution partners,…
SAN CLEMENTE, CA — July 1, 2026 — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This…
For 15 years, we at Reflow Medical have been building, learning, advancing, and continuously challenging what is possible in cardiovascular care. This anniversary is an important milestone for us and…
San Clemente, CA – May 20, 2026 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the presentation of the first six-month clinical…
San Clemente, CA – April 23, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, today announced the U.S. market launch of…
San Clemente, CA – April 13, 2026 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announces that12-month results from the DEEPER…
Fellows and young physicians gained practical experience in real anatomy during October's Practical Vascular Trainee Lab (PVTL), led by Kumar Madassery, MD, and supported by Reflow Medical’s dedicated education station.…
In Chicago, we proudly celebrated the U.S. launch of the Breakthrough Device, Spur Peripheral Retrievable Stent System, a milestone for Reflow Medical and BTK treatment. One highlight was our dedicated…
San Clemente, CA – September 29, 2025 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER…
Recent Comments